Bioindustra ConsortiumFrench team BioAroma awarded with BISC-E 2...At the celebration of the 10th anniversary of the Bio-based Industry Consortium (BIC), the student team BioAroma was presented with the BISC-E 2023 award, which comes with €5000 in prize money. more ➔
Orphan diseasesBreakthrough in microtia treatmentResearchers developed an innovative ear transplant method to treat microtia using tissue-engineered human skin and bioprinted cartilage. more ➔
cell modelsOrakl Oncology SA raises €3m to advance...Paris-based Orakl Oncology SA has raised €3m to develop its techbio platform for precision oncology. more ➔
SepsisSanofi licences vaccine against bacterial...French pharma major Sanofi SA will pay US$175m upfront to Janssen Pharmaceuticals, Inc. for commercialisation of a Phase III vaccine against extraintestinal pathogenic E. coli. more ➔
EventSpain set to unveil the potential of the b...The Spanish EU Council Presidency is to set the course for the internationally competitive use of biotechnology in drug development, plant breeding and food production. more ➔
financingMogrify Ltd extends Series A financing to...British in-vivo cell programming specialist Mogrify Ltd has added US$10m to its US$36m Series A financing. more ➔
RNAJoining forces for mRNA breakthroughDyadic International Inc. and bYoRNA SAS partnered to advance innovative bioproduction technologies for scaling up the production of therapeutic mRNA from C1-Cells. more ➔
FundingSeaBeLife secures €1.2m in fundingBiotech company, specialising in cell necrosis prevention, has announced a successful funding round, securing €1.2m in additional seed funding. more ➔
EventBioSpain breaking recordsWith more than 2,100 attendents, 4,700 partnering meetings so far, BioSpain 2023 is set to break records. more ➔
CollaborationPierre Fabre Laboratories collaborate with...Pierre Fabre Laboratories, a leading French medical and beauty care company and Vernalis (R&D) Ltd, a fully owned subsidiary of HitGen Inc. and a specialist in drug discovery announce a long-term … more ➔
